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Background: The electron transfer flavoprotein (ETF) is a mobile electron carrier coupling mitochondrial fatty acid oxi-
dation to respiration.
Results: METTL20 is a mitochondrial lysine protein methylase that modifies Lys-199 and -202 of the electron transfer flavo-
protein -subunit.
Conclusion:METTL20 is a protein methylase in mitochondria that influences protein-protein interactions with ETF.
Significance:Mitochondria contain lysine methyltransferase METTL20.
In mammalian mitochondria, protein methylation is a rela-
tively uncommon post-transcriptional modification, and the
extent of the mitochondrial protein methylome, the modifying
methyltransferases, and their substrates havebeen little studied.
As shown here, the -subunit of the electron transfer flavopro-
tein (ETF) is one such methylated protein. The ETF is a het-
erodimer of - and -subunits. Lysine residues 199 and 202 of
mature ETF are almost completely trimethylated in bovine
heart mitochondria, whereas ETF is not methylated. The
enzyme responsible for the modifications was identified as
methyltransferase-like protein 20 (METTL20). In human 143B
cells, the methylation of ETF is less extensive and is dimin-
ished further by suppression of METTL20. Tagged METTL20
expressed in HEK293T cells specifically associates with the ETF
and promotes the trimethylation of ETF lysine residues 199
and 202. ETF serves as a mobile electron carrier linking dehy-
drogenases involved in fatty acid oxidation and one-carbon
metabolism to the membrane-associated ubiquinone pool. The
methylated residues in ETF are immediately adjacent to a pro-
tein loop that recognizes and binds to the dehydrogenases. Sup-
pression of trimethylation of ETF in mouse C2C12 cells oxi-
dizing palmitate as an energy source reduced the consumption
of oxygen by the cells. These experiments suggest that the oxi-
dation of fatty acids in mitochondria and the passage of elec-
trons via the ETFmay be controlled by modulating the protein-
protein interactions between the reduced dehydrogenases and
the -subunit of the ETF by trimethylation of lysine residues.
METTL20 is the first lysine methyltransferase to be found to be
associated with mitochondria.
The post-translational methylation of proteins by methyl-
transferases with S-adenosylmethionine as the methyl donor
occurs primarily on the side chains of lysine and arginine resi-
dues, but histidyl and glutamyl side chains and -amino and
-carboxyl groups can be methylated also (1, 2). The -amino
groups of lysine residues can carry one, two, or three methyl
groups, and the guanidino moieties of arginines can be mono-
methylated, and dimethylated either symmetrically or asymmet-
rically. The remodeling of chromatin by methylation and de-
methylationof lysineandarginine residues inhistones, togetherwith
acetylation and deacetylation of lysines, influences gene expres-
sion, DNA replication, and DNA repair and apoptosis among
other processes (3–7), andmethylation of lysine and arginine res-
idues in non-histone proteins is being associated increasinglywith
the regulation of many other cellular activities (8, 9). Moreover,
lysine residues can also be ubiquitinated and sumoylated, and the
interplay between methylation, acetylation, and these other post-
translational modifications, at the same and neighboring sites,
adds complexity to the regulation of biological processes by post-
translational modification (9–11). The methylation reactions are
catalyzed by methyltransferases, and 30% of known and putative
methyltransferases are associated with diseases including cancer,
inflammation, andmetabolic disorders (12–14).
Hitherto, the methylation of lysine and arginine residues of
proteins found inmitochondria has been little investigated. It is
well known that lysine residues in apocytochrome c are meth-
ylated by Ctm1p in the cytoplasm of Saccharomyces cerevisiae
(15, 16), but this modification has no clear role, and the mam-
malian orthologue is unmodified. Trimethyllysine residues
have been characterized in three proteins isolated directly from
mammalianmitochondria: they are citrate synthase (17), ADP/
ATP translocase (18), and the c-subunit in the rotor of ATP
synthase (19). A dimethylarginine residue has been character-
ized in the NDUFS2 subunit of complex I (20), and a complex
pattern of methylation of three histidine residues has been
found near the N terminus of the NDUFB3 subunit of complex
I (21). In addition to these five methylations characterized in
proteins purified from mitochondria, other human proteins
that locate to mitochondria have been reported in cell-wide
methylome studies to contain methylated lysine and arginine
residues (22, 23).
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With the exceptions of HEMK13 (heme biosynthesis gene K)
and NDUFAF7, the mammalian methyltransferases responsi-
ble for the modifications of mitochondrial proteins, their sub-
cellular locations, and the biological significance of the modifi-
cations are unknown. HEMK1 methylates a glutamine residue
in the mitochondrial translation release factor MTRF1L
(24), and NDUFAF7 symmetrically dimethylates Arg-85 in
the mature NDUFS2 subunit of the multisubunit enzyme,
complex I, an essential step in the assembly of the complex
(25). NDUFAF7 is one of 35 known and possible mitochon-
drial methylases catalogued previously by bioinformatic
analysis (25).
As described below, we have found that another mitochon-
drial protein, the-subunit of the electron transfer flavoprotein
(ETF) is also methylated. The ETF is a heterodimeric complex
of - and -subunits, known as ETF and ETF, respectively
(26–29). It acts as a mobile electron carrier in the matrix of
mitochondria, linking 11 different mitochondrial FAD-con-
taining acyl-CoA dehydrogenases involved in fatty acid -oxi-
dation to the ubiquinone pool of the respiratory chain (30, 31).
The ETF also accepts electrons from sarcosine dehydrogenase
and dimethylglycine dehydrogenase, two enzymes of mito-
chondrial one-carbonmetabolism (32). A “recognition loop” in
ETF recognizes and interacts with these 13 different dehydro-
genases (33, 34), and the sites of methylation are immediately
adjacent to the recognition loop. Once bound to the recogni-
tion loop, the dehydrogenases reduce an FAD prosthetic group
in the ETF. Then the reduced ETF carries the electrons to the
ETF-quinone oxidoreductase bound in the inner mitochon-
drial membrane (35). The precise mode of interaction of ETF
with the quinone oxidoreductase is not known, but ETF is
involved in the formation of this complex (36). Finally, the
reducedETF-quinone oxidoreductase transfers the electrons to
ubiquinone, and the reduced quinone enters the quinone pool,
providing electrons for the cytochrome bc1 complex (complex
III) to reduce cytochrome c.
The location of the methylated lysine residues characterized
in the current study, immediately adjacent to the recognition
loop, suggests that their methylation may influence the inter-
actions of the ETF with the dehydrogenases and possibly with
ETF-quinone oxidoreductase, and that it could provide a
mechanism of regulating the -oxidation of fatty acids. We
have also identified METTL20 (methyltransferase-like pro-
tein 20) as the mitochondrial methyltransferase that intro-
duces methyl groups into two specific lysine residues in
ETF. No protein lysine methyltransferase had been charac-
terized previously in mitochondria.
EXPERIMENTAL PROCEDURES
Cell Culture—Human 143B osteosarcoma cells (ATCCnum-
ber CRL8303) and mouse C2C12 myoblasts (Public Health
England 91031101) were grown at 37 °C inDulbecco’smodified
Eagle’s medium (DMEM) containing 25 mM glucose and sup-
plemented with fetal bovine serum (FBS, 10% v/v), penicillin
(100 units/ml), and streptomycin (0.1 mg/ml) under an atmo-
sphere of 5% CO2. The serum in the media for parental human
embryonic kidney cells (HEK293T) and FLAG-strepII-tagged
METTL20 inducible HEK293T cells was tetracycline-free, and
the media included blasticidin (15 g/ml) and zeocin (100
g/ml), or blasticidin (15 g/ml) and hygromycin (100 g/ml),
respectively.
Plasmid Transfection and Confocal Microscopy—The cDNA
for humanMETTL20 (Thermo Scientific, Loughborough, UK)
was amplified by PCR with the forward and reverse primers:
5-CGCGGATCCGGAATGGCTTTGAGTCTAGGTTGGA-
AAG-3 and 5-ATAGTTTAGCGGCCGCCCAGGCTGAA-
AACCCCACACTGTGC-3, respectively. It was cloned into
the inducible expression vector pcDNA5/FRT/TO (Invitrogen)
with sequences encoding C-terminal FLAG and Strep tags, and
incorporated stably into HEK293T Flp-InTM T-RexTM cells.
Plasmids were transfected into 143B cells with Lipofectamine
2000 (Invitrogen). After 24 h, the mitochondria were labeled
with MitoTracker Orange (200 nM; Invitrogen), and the nuclei
were stained with DAPI (0.4 g/ml). The same cells were fixed
with paraformaldehyde (4%, w/v) and permeabilized with
Triton X-100 (0.5%, v/v). The FLAG-taggedMETTL20 was de-
tectedwithmouseM2 anti-FLAGantibody (Sigma) followed by
Alexa Fluor 488 goat anti-mouse secondary antibody (Invitro-
gen). The fluorescent signal was visualized with a Zeiss 510
LSM confocal microscope (Zeiss, Cambridge, UK).
Preparation of Bovine ETF—Submitochondrial particles
were prepared frombovine heartmitochondria (37). Theywere
centrifuged (37,000 g for 20 min, and then at 110,000 g for
30min), and the supernatant was fractionated at room temper-
ature by ammonium sulfate precipitation. The 60–90% fraction
was re-solubilized in buffer A (pH 7.4) consisting of 25 mM
HEPES and0.1mMEDTA, dialyzed against the samebuffer, and
fractionated by cation exchange chromatography on a HiTrap
SP HP column (1ml; GEHealthcare Bio-Sciences AB, Uppsala,
Sweden). The sample was loaded onto the column equili-
brated in buffer A at a flow rate of 0.5 ml/min, and eluted
with a linear gradient of 0–150 mM NaCl in buffer A over 60
min at room temperature. Fractions containing the partially
purified ETF were analyzed by SDS-PAGE and mass
spectrometry.
Expression and Affinity Purification of Tagged METTL20—
Plasmid pcDNATM5/FRT/TO encodingMETTL20with C-ter-
minal StrepII and FLAG tags was cotransfected in the presence
of Lipofectamine 2000 (Invitrogen) with plasmid pOG44
into human HEK293T Flp-In T-Rex cells (total DNA, 1 g;
pOG44:pcDNA5/FRT/TO, 7:1 by weight) (Invitrogen) (38).
After 24 h, themediumwas replacedwith the selectivemedium
containing blasticidin (15 g/ml) and hygromycin (100 g/ml)
and inducible cell lines expressing the recombinant protein
were selected. Expression of taggedMETTL20 was induced for
3 The abbreviations used are: HEMK1, heme biosynthesis gene K; ETD, elec-
tron transfer dissociation; ETF, electron transfer flavoprotein; METTL12,
methyltransferase-like protein 12; METTL20, methyltransferase-like
protein 20; NDUFAF7, NADH dehydrogenase (ubiquinone) complex I
assembly factor 7; NDUFB3, NADH dehydrogenase (ubiquinone) 1 sub-
complex subunit 3; NDUFS2, NADH dehydrogenase (ubiquinone) iron-
sulfur protein 2; OCR, oxygen consumption rate; SILAC, stable isotope
labeling by amino acids in cell culture; TML, trimethyllysine; DML,
dimethyllysine.
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24 h with doxycycline (20 ng/ml). Mitochondria were prepared
(38) and solubilized in 1% (w/v) n-dodecyl -D-maltoside for
affinity purification of tagged METTL20 and associated pro-
teins. To prepare mitoplasts, cells were suspended at a protein
concentration of 10 mg/ml in PBS-inhibitor (phosphate-buff-
ered saline with complete EDTA-free protease inhibitor from
RocheApplied Science) and enriched formitoplasts by addition
of an equal volume of digitonin (1 mg/ml) in PBS-inhibitor to
give a detergent:protein ratio of 1:10 (w/w) (39). The sample
was centrifuged (11,000 g, 5 min, 4 °C), and mitoplasts were
solubilized from the pellet with 1% (w/v) n-dodecyl -D-malto-
side. The enriched mitochondrial protein preparation was
loaded onto a StrepII tag gravity column (Pierce Spin Column
containing Strep-Tactin-Sepharose) followed by 5 column vol-
umes of wash buffer (20mMHEPES, pH 7.6, 0.2mM EDTA, 150
mM NaCl, 2 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl
fluoride, Roche protease inhibitor (1/50; v/v), and 0.05% (w/v)
n-dodecyl -D-maltoside). Bound protein was eluted with 6
portions of 0.5 column volumes of wash buffer containing 10
mM desthiobiotin. Eluates 1–3 were combined and analyzed by
SDS-PAGE and mass spectrometry.
Suppression of Expression with siRNA—Transcripts of METTL20
were suppressed transiently in human 143B cells with 30 nM
siRNAs and transcripts ofMETTL20 or ETF in mouse C2C12
cells with 100 nM siRNAs (Sigma). Allstars negative control
siRNA (Qiagen, Crawley, UK) was used at the same concentra-
tion as the specific siRNA. Two transfections were performed
at 0 and 72 h. The levels of the transcripts (normalized to
endogenous-actin)were investigated at 48 and 120 h by quan-
titative real-time PCR performed with TaqMan gene expres-
sion assays (Invitrogen) on cDNA prepared with a Cells-to-CT
kit (Invitrogen).Mitoplasts were prepared 48 h after each trans-
fection, and the oxygen consumption rate (OCR) of C2C12 cells
was assessed 48 h after the second transfection.
Protein Analyses—Protein concentrations were estimated by
bicinchoninic acid assay (Pierce, ThermoFisher). Proteins were
fractionated by SDS-PAGE on Novex Tris glycine 10–20%
acrylamide gradient gels (Invitrogen) and transferred electro-
phoretically to an Immobilon Pmembrane (Millipore, Billerica,
MA) for immunodetection. The membrane was washed in PBS
containing 0.01% (v/v) Tween 20 (PBST), and then treated with
a solution of dried skimmed milk, or where anti-methyl anti-
bodies were to be employed, with bovine serum albumin (3%,
w/v) in the same buffer. Bound proteins were reacted with pri-
mary rabbit antibodies with specificities for dimethyllysine and
trimethyllysine (Abcam, Cambridge, UK) for ETF and citrate
synthase (Proteintech,Manchester, UK) andNDUFB8 (Sigma).
Bound rabbit antibodies were peroxidase conjugated with goat
anti-rabbit antiserum (ThermoFisher), and detected with
enhanced chemiluminescence reagents (GE Healthcare).
Mass Spectrometry—Bovine, human, and mouse proteins in
extracts and column fractions were reduced, alkylated, and
fractionated by SDS-PAGE in 12–22 or 10–20% polyacryl-
amide gradient gels, as described before (25). Proteins were
characterized by tandem-MS analysis of tryptic, chymotryptic,
and AspN digests of Coomassie Blue-stained bands or sections
of gel. Extracted peptides were analyzed in a MALDI-TOF-
TOF mass spectrometer (model 4800; AB-Sciex, Warrington
UK) with -cyano-4-hydroxycinnamic acid as matrix, or in an
LTQ OrbiTrap XL-ETD (electron transfer dissociation) mass
spectrometer (Thermo Scientific) coupled to a Proxeon Easy-
nLC (Thermo Scientific) with a C18 column (100 mm 75 m
inner diameter; Nanoseparations, Nieukoop, TheNetherlands)
for reverse-phase fractionation of peptides using an acetonitrile
gradient in 0.1% (v/v) formic acid with a solvent flow rate of 300
nl/min. Peptides were fragmented by collision-induced disso-
ciation with either air (4800 instrument) or nitrogen (LTQ
OrbiTrap XL-ETD), or by ETD with fluoranthene radical
anions (LTQ OrbiTrap XL-ETD) and supplemental activation
(40). MALDI-TOF-TOF data were analyzed with Mascot (41)
(version 2.4.0) using the following parameters: NCBInr data-
base 20120611, taxonomy, Mammalia; precursor ion mass
tolerance 70 ppm; fragment ion mass tolerance 0.8 Da; Met
oxidation variable, Cys-carbamidomethyl fixed (iodoacet-
amide-treated samples) or Cys-propionamide (non-alkylated
samples); trypsin 2-missed cleavages. A significance threshold
of p  0.05 was used for peptide identification. Orbitrap pep-
tide fragmentation data were analyzed using Proteome Discov-
erer 1.3 (Thermo Fisher) with Mascot and Peptide Validator
nodes. The following parameters were employed: UniProt_
2013_04, taxonomy, Mammalia (for bovine and mouse)/Homo
sapiens (for human); precursor ion mass tolerance 5 ppm; frag-
ment ion mass tolerance 0.5 Da; variable modifications, Met
oxidation, Lys/Arg-methyl, Lys/Arg-dimethyl, Lys-trimethyl;
fixed modification Cys-carbamidomethyl; trypsin 2-missed,
AspN_ambic 3-missed, chymotrypsin 4-missed cleavages;
decoy database search (false discovery rate values 0.01 and
0.05). The fragmentation spectra of modified peptides were
interpreted manually. ETD fragment ions were assigned as c
and z ions (including related zH ions) (42). The relative abun-
dance of methylation of ETFwas determined by analysis of an
AspN-generated peptide (EPRYATLPNIMKAKKKKI) that
contains both methylated lysine residues. Monoisotopic m/z
values used are 710.4263 and 715.7579 (M  3H)3, plus
533.0717 and 537.0704 (M  4H)4 for the non-methylated
and non-methylated/Met-oxidized forms of the peptide,
respectively. 14.0156 Da were added for each methyl group.
The peak areas of Gaussian smoothed extracted ion chromato-
grams, with am/z tolerance of 5 ppm and overlapping peptide
retention times, were obtained with the aid of Xcalibur soft-
ware. The intact bovine ETF subunits were separated by
reverse-phase chromatography and their molecular masses
were determined by LC-MS (43).
Protein Quantitation of SILAC-labeled Samples—Inducible
HEK293T cells expressing either taggedMETTL20 orMETTL12
were grown in “heavy” DMEM containing arginine and lysine
isotopically labeled with 15N and 13C, and in “light” DMEM
containing 14N- and 12C-arginine and -lysine (Sigma) (44).
These media were supplemented with penicillin (100 units/ml)
and streptomycin (0.1 mg/ml), and proline (200 mg/liter) to
suppress the conversion of arginine to proline, and with dia-
lyzed FBS (10% v/v) (Invitrogen) to prevent dilution of heavy
isotopes. To ensuremaximal incorporation, the cell population
was doubled at least seven times.
Cells were mixed 1:1 (protein w/w) and consisted of at least
10 mg of protein from each of the heavy and light isotope-
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labeled cultures. Then mitoplasts were prepared and samples
for analysis consisted of StrepII-tag affinity-purified proteins as
described under “Expression and Affinity Purification of
Tagged METTL20.” The protein samples were fractionated by
SDS-PAGE, andCoomassie Blue-stained gel slices were subject
to in-gel trypsin digestion and analysis in an LTQ Orbitrap
XL-ETDas described above. Eachmass spectrometric ratiowas
based on two SILAC analyses. In the first orientation, the cell
line over-expressing METTL20 was labeled in heavy medium
and a control cell line in whichMETTL12was overexpressed in
light medium, and vice versa in the second orientation. Protein
identification and relative quantification was performed with
MaxQuant and the integrated Andromeda search engine, with
the Perseus program used for subsequent bioinformatic and
statistical analyses (45–47). Heavy and light peptide pairs were
quantified with MaxQuant (version 1.3.0.5) and the following
parameters used: Fasta database: IPIHuman (version 3.68), oxi-
dation (M) and acetyl (protein N-term) variable; Cys-car-
bamidomethyl fixed; MS/MS balance 0.5 Da; minimum ratio
count 2; Arg-10 and Lys-8. Themedian peptide ratio was taken
to be the protein ratio, using at least two values. The ratios from
each experiment were plotted on horizontal and vertical axes,
respectively, of a “scatter plot” as the log base 2 value. Thus, a
4-fold change in the abundance of a protein in both experi-
ments becomes 2 on each axis and the protein is represented by
a point in the top right or bottom left quadrant of the scatter
plot. Proteins unaffected by the experimental condition are
clustered around the intersection of the x and y axes. A diagonal
line extending from the top right to bottom left quadrants rep-
resent a perfect correlation between the two experiments. Sta-
tistically significant proteins in both orientations of labeling
were identified with Perseus (p 0.05). Points in the two other
quadrants represent proteins where the quantification differ-
ences are not reproducible in the replicate experiments. Those
in the top left quadrant contain unlabeled external contami-
nants such as keratins or dermcidin. SILAC experiments were
performed twice with each labeling orientation. A comprehen-
sive account of the SILAC methodology and data analysis used
here has been described previously (45–47).
Measurement of Respiration—Mouse C2C12 cells were
transfected twice at 0 and 72 h, with 100 nM siRNA of negative
control, METTL20, or ETF. The OCR of transfected cells was
measured in an XF96 extracellular flux analyzer (Seahorse Bio-
sciences, MA) at 120 h. The assay medium consisted of 70 mM
sucrose, 220mMmannitol, 10 mMKH2PO4, 5 mMMgCl2, 2 mM
HEPES, 1 mM EGTA, 0.2% (w/v) fatty acid-free BSA (pH 7.4),
and 4 mM ADP. The cells were treated with 1 nM XF plasma
membrane permeabilizer reagent (Seahorse Biosciences). When
the OCR reached a stable baseline, 40 M palmitoyl-L-carnitine
chloride supplemented with 0.2 mM malate was added. Respira-
tion was normalized to cell number by the sulforhodamine B
colorimetric assay (48). p values for the OCR were calculated
with a paired Student’s t test.
Structural Analyses—The mitochondrial targeting sequence
of METTL20 was predicted with Mitoprot (49) and its second-
ary structure with Jpred3 (50). Sequences were aligned with
ClustalW. The structure of the region of interaction between
the recognition loop in recombinant human ETF and MCAD
(33) was produced with PyMol using Protein Data Bank code
1t9g (51).
RESULTS
Mitochondrial Methyltransferases—Previously, a catalogue
of 35 known and possible mitochondrial methyltransferases
was compiled (25). In this list, the functions of seven established
mitochondrial proteins have been demonstrated: four aremito-
chondrial RNA methyltransferases, NDUFAF7 is a mitochon-
drial arginine-methyltransferase, and twoothers are involved in
ubiquinone biosynthesis. To this catalogue can be added the
catechol O-methyltransferase and catechol O-methyltrans-
ferase domain containing protein-1 (52, 53), and the N5 gluta-
mine methyltransferase, HEMK1 (24). The list is dominated by
the family of 7-strand methyltransferases (25). As part of a
wider investigation of protein methyltransferases in mitochon-
dria, one highly conserved member of the 7-strand family,
METTL20, was chosen for study. Another possible methyl-
transferase,METTL12 (methyltransferase-like protein 12), was
used as a control in experiments employing SILAC designed to
identify binding partners of METTL20 (see below). Both
METTL12 and METTL20 localized to the mitochondria of
human 143B cells (Fig. 1).
Interaction between METTL20 and ETF—Four proteins,
ETF, ETF, and the heat shock proteins, HSP60 and HSP70,
were found associated with a tagged version of METTL20 (Fig.
2A). Authentic binding partners were distinguished from non-
specifically interacting proteins and exogenous contaminants,
by quantitative mass spectrometry of SILAC-labeled samples
(Fig. 2B). This experiment confirmed that ETF andETFwere
associated significantly with METTL20. There was also a sug-
gestion of a possible association between METTL20 and
HSP60, but the experiment provided no support for the possi-
bility of a specific interaction between METTL20 and HSP70.
In other experiments (not shown), no evidence was found for
the methylation of human HSP60.
Methylation of the -Subunit of the ETF in Bovine and
Human Mitochondria—The methylation status of the - and
-subunits of the readily available bovine ETFwas examined by
measuring their molecular masses (Table 1), and by verifying
the sequences by analysis of proteolytic peptides. The mass of
anAspN peptide (referred to as DN-(188–205)) containing five
lysine residues and representing residues 188–205 of mature
ETF indicated that the protein was methylated in this region,
and a spectrum arising from the fragmentation by ETD of a
quadruply charged ion of this peptide with m/z 554.1 revealed
that lysine residues 199 and 202 were trimethylated (92% at
both sites), whereas lysine residues 201, 203, and 204 were
unmodified (Fig. 3A). The accurate peptide mass (M  H
2213.3571) showed that the modification at each site was tri-
methylation (M  H 2213.3571) and not acetylation (M  H
2213.2843). There was no evidence for non-methylated or sin-
gly methylated species, but 7.8% of the peptide carried five
methyl groups and the remaining 0.2% was accounted for by
forms with the two lysine residues jointly carrying two, three,
and four methyl groups. ETF has no processed N-terminal
mitochondrial targeting sequence (54), and analysis of the
N-terminal AspN peptide showed that the translational initia-
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tor methionine residue had been removed, and that the result-
ing N-terminal alanine residue had been N-acetylated (Fig.
3B). When this modification and the presence of the two tri-
methylated lysine residues are taken into account, the intact
molecularmass of ETF agrees closelywith the calculated value
(Table 1). In contrast, no methylated amino acid was detected
in proteolytic digests of mature ETF including Arg-204
reported recently to be monomethylated (23). The experimen-
tally determined mass of intact ETF was accounted for by the
presence of proline at position 239 (Fig. 3C), and the removal
of the 19-amino acid predicted N-terminal mitochondrial
targeting sequence (49, 54) followed by cyclization of the
resulting N-terminal Gln residue to pyroglutamate. The
sequence of DN-(188–205) from human ETF is identical to
that of the bovine peptide, and lysine residues 199 and 202
were trimethylated also (Fig. 4A). These residues are highly
conserved (34).
Effect of Overexpression and Suppression of Expression of
METTL20—The overexpression of tagged METTL20 in human
HEK293Tcells was accompanied by a significant increase in the
trimethylation of ETF (without effect on the methylation of
the adenine nucleotide carrier), as indicated by a strong cross-
reactivity with a trimethyllysine (TML)-specific antibody and
an absence of cross-reactivity with a dimethyllysine antibody
(DML) (Fig. 4B). Mass spectrometry analyses of ETF demon-
strated that lysines 199 and 202 were both trimethylated com-
FIGURE 1. Subcellular location ofMETTL20 andMETTL12.METTL20 orMETTL12, eachwith C-terminal StrepII and FLAG tagswere expressed in human 143B
cells (upper and lower panels, respectively). A, cell nucleus stained with DAPI (blue). B, recombinant METTL20 or recombinant METTL12 detected with an
anti-FLAG antibody, plus goat anti-mouse Alexa Fluor 488 (green). C, mitochondria stained with MitoTracker (red). D, merged areas of A–C.
FIGURE 2. Identification of proteins associated withMETTL20. A, SDS-PAGE analysis of METTL20 and associated proteins purified by affinity chromatogra-
phy from Flp-In T-REx HEK293T cells expressing FLAG-StrepII-tagged METTL20. Lane a, molecular mass marker proteins (molecular masses indicated on the
left); lane b, solubilizedmitochondria; lane c, unbound proteins; lanes d and e, first and final columnwashes; lanes f–h, eluates 1, 3, and 5; on the right of the gel
are shown the identities of the stained bands determined by tandem-MS analysis of tryptic peptides from the bands in lanes f and g. B, quantitative mass
spectrometry of METTL20 and associated proteins. SILAC-labeled cells from METTL20 and differentially labeled control cells overexpressing METTL12 were
combined and purified as above. The experiment was performed in both labeling orientations (orientation 1, METTL20-heavy plusMETTL12-light; orientation
2,METTL20-lightplusMETTL12-heavy). Eachdatapoint corresponds to theabundance ratioof an identifiedprotein fromthe twocomplementary experiments.
f,METTL20 andMETTL12;●, proteins significantly associatedwithMETTL20orMETTL12 inbothorientations;‚, 721proteins that comprise 709 insignificantly
associated with either tagged-protein (including HSP70) and 12 proteins with one significant orientation only, including HSP60;, exogenous contaminant
(DCD, dermcidin).
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FIGURE 3. Post-translational modifications of bovine ETF and the presence of proline at position 239 of bovine ETF. A, ETD fragmentation mass
spectrumof peptide DN-(188–205) of ETF frombovine heartmitochondria, with series of c ions and z ions generated from the [M 4H]4 precursor ion,m/z
554.09, mapped onto the sequence of the peptide. B, sequence of the N-terminal peptide of bovine ETF. An ETD fragmentation mass spectrum is shown of
a triply charged ion,m/z 493.98, generated by cleavage of the protein with AspN. In the inset, the series of c and z fragment ions identified the peptide as the
N-terminal fragment, and demonstrated that the-amino group of Ala-1 is acetylated. C, aMALDI-TOF-TOF fragmentationmass spectrum is shown of a singly
charged ion,m/z1886.96, of a trypticpeptide fromthebovineETF-subunit. In the inset, the seriesofband y fragment ions shows that thepeptide corresponds
to residues 231–249, and the y9 and y11 ions define the sequence Pro-Asn, and demonstrates the presence of proline and not threonine at position 239.
TABLE 1
Molecular masses of bovine mitochondrial ETF and ETF
Aprotein fraction containing ETFwas prepared from bovinemitochondrial matrix by ammonium sulfate precipitation and cation exchange chromatography. It was separated by
reverse-phase chromatography on anmRP column (75 1mm inner diameter, 5-mparticles) and the protein molecular masses were determined by LC-MS (43).
Subunit
Mass (Da)
PTMs DifferencebObserved
Calculated
Unmodified Modifieda
 32,798.2 34,957.5 32,795.9c 1–19; Gln-1 cyclized to pyro-Glu 2.3
 27,695.4 27,699.5 27,694.5 - Initiator Met; N-acetyl-Ala-1; Lys-199
and Lys-202 trimethylated
0.9
a Calculated after applying the post-translational modifications (PTMs) to the unmodified sequence, 1–19 denotes the N-terminal mitochondrial targeting sequence for
ETF that is removed after import.
b Difference (Da) between the observed molecular mass value and the calculated modified mass.
c Residue 239 of mature bovine ETF has been reported to be either proline or threonine; only proline was observed.
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pletely in these cells (Fig. 4C). In control cells, the trimethyla-
tion of ETFwas less extensive and the protein exhibited strong
cross-reactivity only with the DML-specific antibody (Fig. 4B),
and there was no evidence of complete methylation of both
lysine residues; 17.2% of DN-(188–205) was unmethylated and
9.2, 37.4, 13.6, 11.8, and 10.8%of the peptide carried 1–5methyl
groups, respectively (Fig. 4C).
In a complementary experiment, the expression of METTL20
was suppressed transiently in human 143B cells. After 120 h, the
level of the METTL20 transcript had been reduced by at least
70% (data not shown). The protein level of ETFwas unaltered
in these cells, and there was no evidence of methylation in
Western blotting experiments usingDMLandTMLantibodies,
in contrast to control cells, which showed only a strong anti-
DML reactivity (Fig. 4D). Mass spectrometric analysis of
DN-(188–205) showed that suppression of expression of
METTL20 was accompanied by 92.4% of ETF becoming
unmethylated; 5.6% was monomethylated, and 2% carried 2–4
methyl groups (Fig. 4E).
Influence of the Methylation of ETF on the Oxidation of
Fatty Acids—The proximity of methylated lysines 199 and 202
to the recognition loop of ETF suggested the possibility that
their methylationmight influence the interaction of ETFwith
the acyl-CoA dehydrogenases, and thereby affect fatty acid oxi-
dation.Mouse C2C12myoblasts were employed, as, in contrast
to human 143B and HEK cells, they can generate energy from
fatty acids. The sequence of DN-(188–205) from mouse ETF
is identical to that of the bovine and human peptide. In control
C2C12 cells, lysine residues 199 and 202 of mouse ETF were
trimethylated extensively (Fig. 5A) and to a greater extent than
the methylation of ETF in human HEK and 143B cells (Fig. 4,
C and E). Transient suppression of the expression ofMETTL20
reduced themethylation of ETF (Fig. 5B) with no effect on the
expression of ETF. After 48 h, trimethylation had decreased
with a concomitant increase in dimethylation, and after 120 h
the trimethylationhaddiminishedeven further.Mass spectromet-
ric analysis of DN-(188–205) showed that increased suppression
of expression ofMETTL20 from 48 to 120 h was accompanied by
FIGURE4.Trimethylationof lysines199and202ofhumanETFand influenceofMETTL20on theirmethylation.A–C, samples ofmitoplasts fromhuman
HEK293T cells expressing tagged METTL20 (t-METTL20), and from control cells. A, ETD fragmentation mass spectrum of peptide DN-(188–205) of ETF from
t-METTL20 cells, with a series of c ions and z ions generated from the [M 4H]4 precursor ion mapped onto the sequence of the peptide. B, fractionation of
mitoplasts by SDS-PAGE andWestern blottingwith antibodies against TML, DML, ETF, citrate synthase (CS), and the NDUFB8 subunit of complex I, employed
as loading controls. C, quantitation of methylation states of the DN-(188–205) peptide. Themethylation states of the individual Lys-199 and Lys-202 were not
resolved. The histogramswere derived from the extracted ion chromatograms for them/z values of all possiblemethylation states of DN-(188–205). Thewhite,
pale gray,gray,diagonal striped,dark gray,horizontal striped, andblack sections represent 0–6methyl groups, respectively, in thepeptide.D and E, human143B
osteosarcoma cells were transfected twice at 0 and 72 h with siRNA specific for METTL20 (si-METTL20) and negative control siRNA, and mitoplasts were
prepared from the cells at 120 h.D, fractionation ofmitoplasts by SDS-PAGE, andWestern blotting with antibodies against TML, DML, ETF, and CS employed
as a loading control. E, quantitation of methylation states of DN-(188–205). For an explanation of the shading, see the legend to panel C. In theWestern blots,
control 143B andHEK293T cells exhibit a stronger andmore specific signalwith aDMLantibody thanwith an antibody against TML reflecting the less extensive
methylation of ETF in these cells.
Methylation of the Electron Transfer Flavoprotein byMETTL20
24646 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 35•AUGUST 29, 2014
decreasedmethylation of lysines 199 and 202, in comparisonwith
controls (Fig. 5C). Thus, the suppression of expression of mouse
METTL20 had a similar effect on the methylation of ETF to the
suppression of the human orthologue.
The role of themethylation of ETF on the oxidation of fatty
acids in C2C12 cells was examined by measuring the rate of
consumption of oxygen in permeabilizedmouse C2C12 cells in
assay media containing palmitoylcarnitine. At 120 h, suppres-
sion of expression of METTL20 was accompanied by a reduc-
tion of 14% in theOCR relative to control cells (t test, p 0.05),
whereas the suppression of expression of ETF led to a
decrease of 60% in the rate of consumption of oxygen (t test, p
0.001) (Fig. 5D). No difference in OCR was observed with glu-
tamate-malate, rotenone, succinate, and antimycin A (data not
shown). These findings indicate that the trimethylation of
lysine residues 199 and 202 of ETF by METTL20 influences
the oxidation of fatty acids.
DISCUSSION
Subcellular Site of Methylation ofMitochondrial Proteins—It
is conceivable that methylation of the nuclear-encoded pro-
teins found in thematrix of mitochondria or in the inner mem-
branes might take place either during or after cytoplasmic
protein synthesis but before import of the protein into the
organelle, or during or on completion of import of the protein
and cleavage of any mitochondrial targeting sequence. The
experiments described here show that METTL20 is a protein
lysine methylase associated with human mitochondria, most
likely localized to the matrix space, and that it catalyzes the
methylation of lysines 199 and 202 in the mitochondrial matrix
protein, ETF, probably during or following its import into the
matrix. Recently, the arginine methyltransferase, NDUFAF7,
has also been localized to human mitochondria and shown to
methylate Arg-85 of the NDUFS2 subunit in the membrane
extrinsic arm of complex I (25). Together, these studies provide
the first evidence that both lysine and arginine protein methyl-
transferases are found inmitochondria, probably in the matrix.
With the exception of apocytochrome c, which ismethylated in
the cytoplasm of yeast cells, and the mitochondrial translation
release factor MTRF1L methylated by HEMK1 (24), the modi-
fying enzymes, and the subcellular sites of methylation of other
mitochondrial proteins remain to be established.
Structure and Function of METTL20—The classification of
METTL20 as a 7-strandmethyltransferase (13) provides clues
about both its structure and function. This protein family is
characterized by a common core similar to aRossman-foldwith
FIGURE 5. Effect of suppression of expression ofMETTL20 on themethylation of ETF and the oxidation of palmitoylcarnitine inmouse C2C12 cells.
Mouse C2C12myoblasts were transfected at 0 and 72 h with specific siRNAs for ETF andMETTL20 (si-ETF and si-METTL20, respectively), and with negative
control siRNA. A, ETD fragmentation mass spectrum of peptide DN-(188–205) of ETF from mouse C2C12 control cells, with a series of c ions and z ions
generated from the [M4H]4precursor ionmappedonto the sequenceof thepeptide.B,mitoplasts prepared at 48 and120h fractionatedbySDS-PAGE, and
Western blottedwith antibodies against ETF, DML, TML, and citrate synthase (CS). ANT, adenine nucleotide translocase. C, quantitation ofmethylation states
of mouse DN-(188–205). For an explanation of the shading, see the legend to Fig. 4C. D, the cells were transfected with siRNA at 0 and 72 h. The OCR was
measured at 120 h in permeabilized cells before and after the addition of 40 M palmitoyl-L-carnitine chloride supplemented with 0.2 mM malate. The values
normalized to cell number are the mean S.E. (n 16 per group).
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a twisted seven-stranded -sheet structure (strands 1–7 in Fig.
6) with, in the case of METTL20, five associated -helices (Z2,
A, B,D, andE in Fig. 6) rather than themore usual six associated
-helices in other familymembers. Based on known structures,
the site for binding S-adenosylmethionine is mainly in loop
regions extending from theC-terminal ends of-sheets 1 and 2,
plus conserved sequence motifs I and post I. The region of
METTL20 that is likely to be involved in binding the protein
substrate, ETF, probably involves the regions following -sheets
4 and 5. Characteristic sequence motifs II and III include these
regions (55, 56).
METTL20 has also been grouped in the protein domain fam-
ily Methyltransf_16 (57, 58) with nine related human proteins
that have been proposed to methylate chaperone proteins
preferentially. They include METTL18, the possible human
homolog of yeast YIL110W, which monomethylates His-243
in ribosomal protein Rpl3 (59), and CaM-KMT, METTL21A,
METTL21D, andMETTL22, which trimethylate lysines in cal-
modulin, in HSP70 family members, in valosin-containing pro-
tein, and in DNA/RNA-binding protein KIN17, respectively
(12, 57, 58, 60). In the present work, analysis of SILAC samples
provided clear evidence of association of METTL20 with the
ETF. There was much weaker evidence of the possible associa-
tion of METTL20 with mitochondrial HSP60, which has been
reported to contain monomethylated Lys-490, although the
extent of methylation was not determined (22). In contrast, in
the current experiments, which demonstrate unequivocally the
methylation of ETF by METTL20, there was no evidence of
methylation of HSP60 either under normal growth conditions
or when METTL20 was suppressed or overexpressed (data not
shown). Therefore, it is unlikely that METTL20 methylates
human mitochondrial HSP60.
Methylation of the ETF as a Regulatory Mechanism—The
trimethylation of a lysine residue changes its properties by con-
ferring a permanent positive charge on its side chain, and by
increasing its bulk and hydrophobicity. Thus, the methylation
and demethylation of proteins provides a means of modulating
interactions between proteins, as exemplified by interactions
between histones and their binding partners (3–7). Increas-
ingly, it is becoming recognized as amechanism for influencing
interactions between non-histone proteins also (8, 9, 61), but as
yet, there is no evidence for the presence of protein demethyl-
FIGURE 6. The structure of human METTL20. A, predicted secondary structures within the sequence of mature METTL20. The locations of -helices and
-sheets are indicated above the sequence by rods and arrows, respectively. -Sheets 1–7 and intervening -helices A-E characterize the 7-strand methyl-
transferase-fold. Helix C, intervening between strands 3 and 4 in other familymembers, is not present inMETTL20. Helix Z1 and sheet Z are not part of the fold.
Conserved motifs I, post I, II, and III are also found in 7-strand methyltransferases (56). Motif III consists of -strand 5 and the amino acid residues preceding
it. Post II motif ((D/E)XX(Y/F)) is conserved in 9 other relatedmethyltransferases (58). B, topology of the 7-strand fold and flanking -helices. Triangles, circles,
and lines represent -strands, -helices, and joining loops, respectively. The positions of the substrate binding sites are shown.
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ases in mitochondria that might be involved in such a regula-
tory mechanism. However, the location of methylated lysines
199 and 202 immediately adjacent to the highly conserved
recognition loop in ETF (Fig. 7A) suggested that they may
be involved in modulating the interaction of the ETF with
dehydrogenases, and possibly with the ETF-ubiquinone oxi-
doreductase also. The recognition loop has the remarkable
property of recognizing and interacting with as many as 13 dif-
ferent acyl-CoAdehydrogenases so as to allow electron transfer
between the dehydrogenases and the ETF (30, 31, 34). The
structure has been determined of the ETF in complex with one
suchdehydrogenase, themediumchain acyl-coenzymeAdehy-
drogenase (33). The recognition loop consists of an extended
region from residues 189–193 and the N-terminal region (res-
idues 194–198) of an -helix, and is followed in the same -he-
lix (residues 199–203) by methylated lysine residues 199 and
202 (Fig. 7B). This structure was determined with unmethyl-
ated recombinant human ETF. In the free ETF, Lys-199 and
Lys-202 would be in exposed positions, where they would be
amenable to methylation by METTL20, whereas lysines 201,
203, and 204 are buried and are not methylated. The introduc-
tion of up to six collectively bulky methyl groups in lysines 199
and 202 would be likely to alter the interaction of the ETF with
the dehydrogenase. ETF interacts also with the ETF-ubiqui-
none oxidoreductase bound in the inner mitochondrial mem-
brane (36). Hitherto, no structure has been described of the
complex between the ETF and the ubiquinone oxidoreductase,
and so it is not known whether their interaction also involves
the recognition loop and lysine residues 199 and 202.
In contrast to 143B and HEK cells, C2C12 cells are able to
respire using fatty acids. In the present work, the extent of
methylation of ETF was demonstrably higher in C2C12 cells
compared with 143B and HEK cells, which implies it has a rel-
evant biological function depending on the energetic sub-
strates. Furthermore, the reduction of methylation of lysine
residues 199 and 202 by suppression of METTL20 in C2C12
cells that are oxidizing palmitoylcarnitine decreased its oxida-
tion. Therefore, the methylation of these lysines influences
fatty acid oxidation probably by modulating protein-protein
interactions involving ETF. Such a mechanism could be
involved in the formation of a multifunctional fatty acid oxi-
dation complex that was reported to interact with OXPHOS
supercomplexes (62).
Mutations in ETF and ETF and in the ETF-ubiquinone
oxidoreductase are associated with the human inherited meta-
bolic disease, glutaric acidemia type II or multiple acyl-CoA
dehydrogenase deficiency (63, 64), and deletion of Lys-201 in
mature ETFhas been observed in a patient suffering fromETF
deficiency (65). It was postulated that themutation disrupts the
local structure and impacts on the ETF partner complex forma-
tion due to the close proximity of Lys-201 to the recognition
loop (33). It remains to be established whether mutations in
METTL20 that would affect the methylation of lysine resi-
dues 199 and 202 of ETF are also associated with metabolic
diseases.
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